investing in transformative technology
Accelerating innovation in biosensing and data-driven healthcare
Dexcom Ventures builds upon the foundation of excellence established by Dexcom, a leader of diabetes care technology. Dexcom Ventures is defining a pathway to supplement growth in our core business, while advancing development into other chronic health conditions beyond diabetes.
our foundation of excellence
-
Mission
Dexcom Ventures seeks and invests in opportunities to drive the next wave of health innovations, via a world-class venture capital platform.
-
Strategy
Identify and invest in promising transformational technology platforms adjacent to or related to the Dexcom core strategy, often contrarian or symmetrical bets, that can drive and accelerate their development.
-
Leadership
Our leadership leverages 20+ years of combined experience that helped shape Dexcom into a multibillion-dollar company, one rooted in transformational technology.
-
Collaboration
We seek investee companies that share our goal to help increase global access to timely health data, for better health care and outcomes across populations.
our featured portfolio
Not all investments are publicly announced.
-
Medcrypt
Helping healthcare technology companies ensure medical devices are secure by design. Providing cybersecurity products and strategic management consulting to expedite the go-to-market process of medical device manufacturers' new life-saving connected technologies.
-
Nutromics
Revolutionises healthcare through Continuous Molecular Monitoring (CMM), with a vision for a world with zero preventable deaths through personalized and timely molecular insights.
-
Epitel
Develops long-term wearables that make medical-grade seizure monitoring more accessible.
-
Signos
Combines CGM technology with an AI-driven app to deliver real-time glucose monitoring for optimal health and weight management.
-
BiointelliSense
Enables medical-grade Remote Patient Monitoring Hospital at Home (RPM-H@H) via its BioSticker-based data service.
-
Beta Bionics
Focused on the design, development, and launch of the the iLet® Bionic Pancreas, an insulin delivery device.
together, we can do more
We are excited to explore what’s possible with your partnership. Contact us to learn more about how Dexcom Ventures may be able to collaborate with your team.
meet the team
Jason Halac
Managing Director, Dexcom Ventures
Jason is the co-founder and Managing Director of Dexcom Ventures, where he leads technology scouting and strategic pipeline development. Leveraging industry expertise and technology leadership developed at Dexcom, he aims to build a Dexcom Ventures portfolio of value-added strategic investments.
